Salvador G. D.
- Country
- Spain
- Department
- Cornea and Refractive Surgery
Research Overview
- Evaluation of Timbetasin Acetate Ophthalmic Solution 0.1% for Neurotrophic Keratopathy: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study
- SEER-3: A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy
Data & Insights
Has run more than one trial at 7 of 24 partner sites.
Specializations
Ophthalmology Specialization
The investigator demonstrates dedicated expertise in ophthalmological disorders, with particular emphasis on corneal conditions. Their research centers on innovative therapeutic approaches for rare ocular surface diseases.
- Corneal Disease Management
- Ocular Surface Disorders
- Advanced Therapeutic Solutions
Neurotrophic Conditions
Specializing in the treatment of neurotrophic keratopathy, the investigator explores novel therapeutic interventions for this rare degenerative corneal condition. Their work focuses on developing treatments that address underlying nerve dysfunction in the cornea.
- Corneal Nerve Disorders
- Degenerative Eye Conditions
- Therapeutic Innovation
Clinical Applications
The investigator's work encompasses the evaluation of ophthalmic solutions for treating corneal conditions. Their expertise extends to assessing innovative treatments for improving ocular surface health.
- Topical Treatments
- Eye Disease Management
- Clinical Assessment Methods
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.